Abiopharma

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026

LandBridge Forms Special Committee to Evaluate Potential Corporate Conversion

Total Voting Rights and Transaction in Own Shares

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA

Aeries Technology Secures Strategic GCC Advisory Mandate with Leading Global Tax and Financial Advisory Platform

Jet.AI Announces New Record Date for Distribution of SpinCo Shares in Connection with Proposed flyExclusive Transaction

Fate Therapeutics Appoints Laura Hamill to Board of Directors

WaterBridge To Join Alerian Indexes; Forms Special Committee to Evaluate Potential Corporate Conversion

Pagaya Issues AAA-rated Upsized $800 Million Personal Loan ABS Transaction

Capstone Energy+ to Host Fourth Quarter and Full Fiscal Year 2026 Earnings Conference Call on June 25, 2026